Karyopharm Therapeutics Inc.KPTINASDAQ
LOADING
|||
Switch Symbol:
Operating Income Contraction
Profitability under pressure
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-119.44M
↑ 14% above average
Average (9y)
$-139.08M
Historical baseline
Range
High:$-98.27M
Low:$-189.28M
CAGR
+0.0%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-119.44M | +7.8% |
| 2023 | $-129.54M | +8.9% |
| 2022 | $-142.20M | -44.7% |
| 2021 | $-98.27M | +42.8% |
| 2020 | $-171.85M | +9.2% |
| 2019 | $-189.28M | -5.2% |
| 2018 | $-179.88M | -37.8% |
| 2017 | $-130.54M | -17.9% |
| 2016 | $-110.73M | +7.0% |
| 2015 | $-119.08M | - |